Core Viewpoint - Liyuanheng (688499.SH) reported a significant increase in losses for 2024, with a net profit loss of 1.044 billion yuan, a 455% increase from the previous year's loss of 188 million yuan, and a revenue decline of 50.30% to 2.482 billion yuan, primarily due to reduced demand in the domestic new energy market and extended delivery cycles [2][3]. Financial Performance - In 2024, Liyuanheng achieved a revenue of 2.482 billion yuan, a decrease of 50.30% year-on-year, and a net profit loss of 1.044 billion yuan compared to a loss of 188 million yuan in the previous year [3]. - The company's gross profit margin for 2024 was 7.77%, down 18.67 percentage points from the previous year [3]. - In Q1 2025, Liyuanheng showed signs of recovery with a revenue of 715 million yuan, a 6% decline year-on-year, and a net profit of 12.82 million yuan, reversing the loss from Q1 2024 [4]. Market Conditions - The decline in performance is attributed to a slowdown in the domestic new energy market, a decrease in order volume, and extended delivery and acceptance cycles [3][7]. - Increased competition in the power lithium battery equipment market has led to price concessions during bidding, further impacting revenue and gross margin [3]. Order and Client Dynamics - As of May 31, 2025, Liyuanheng had an order backlog of 4.921 billion yuan, with a significant portion coming from well-known domestic and international lithium battery manufacturers [4]. - The proportion of consumer lithium equipment orders increased to 32.21%, reflecting a recovery in demand in the consumer electronics market [4][5]. Accounts Receivable Issues - As of December 31, 2024, Liyuanheng's accounts receivable amounted to 1.602 billion yuan, with the top five clients accounting for 71.53% of this total [6]. - The aging of accounts receivable is concerning, with 54.93% of the balance being overdue by 1-2 years, leading to a higher bad debt provision of 3.65 billion yuan [6][8]. Financial Strategy and Measures - To address liquidity issues, Liyuanheng increased bank borrowings, resulting in financial expenses of 99.58 million yuan in 2024, a 50.62% increase from 2023 [8]. - The company has implemented measures to improve cash flow, including establishing a communication mechanism with clients to expedite payment processes [8].

Group 1: Hand Return Group - Hand Return Group plans to list on the Hong Kong Stock Exchange on May 30, 2025, with the stock code "2621" [3] - The IPO will issue a total of 24,358,400 shares, with a subscription rate of 990 times for the Hong Kong public offering and 1.13 times for the international offering [3] - The company aims to provide insurance service solutions through its online platform, with three main platforms: Xiao Yusan, Kachaba, and Niu Bao 100 [3] - Hand Return Group is the second-largest online insurance intermediary in China, holding a 7.3% market share in long-term life insurance premiums as of 2023 [4] - The company has distributed over 1,900 products since its establishment, including more than 280 customized products [4] - Financial data shows revenues of 806 million, 1.634 billion, and 1.387 billion CNY from 2022 to 2024, with adjusted net profits of 75 million, 253 million, and 242 million CNY respectively [5] Group 2: Yingshi Innovation - Yingshi Innovation plans to open subscriptions on May 30, 2025, and is expected to list on the Sci-Tech Innovation Board in mid-June [7] - The company will issue 41 million new shares, with 20% allocated for strategic placement [7] - Yingshi Innovation specializes in smart imaging devices, focusing on panoramic and action cameras, with a global market share of 67.2% in panoramic cameras as of 2023 [8] Group 3: Lin Qingxuan - Lin Qingxuan submitted its prospectus to the Hong Kong Stock Exchange on May 29, 2025, aiming for a main board listing [10] - The brand ranks first among domestic high-end skincare brands in China by retail sales as of 2024 [11] - Financial data indicates revenues of 691 million, 805 million, and 1.21 billion CNY from 2022 to 2024, with a compound annual growth rate of 32.5% [11] Group 4: Yushi Technology - Yushi Technology submitted its prospectus on May 28, 2025, planning to list on the Hong Kong Stock Exchange [14] - The company is the largest supplier of L4-level autonomous driving solutions for airport and factory scenarios in Greater China as of 2024 [15] - Financial data shows revenues of 66 million, 161 million, and 266 million CNY from 2022 to 2024, with a compound annual growth rate of 101.3% [15] Group 5: Yisiwei Computing - Yisiwei Computing submitted its prospectus on May 30, 2025, aiming for a main board listing [19] - The company is a leading provider of RISC-V solutions in China, with over 100 system-level solutions commercialized as of 2024 [20] - Financial data indicates revenues of 2 billion, 1.752 billion, and 2.025 billion CNY from 2022 to 2024 [20] Group 6: Xian Gong Intelligent - Xian Gong Intelligent submitted its prospectus on May 27, 2025, planning to list on the Hong Kong Stock Exchange [22] - The company ranks first in global robot controller sales for two consecutive years, with a market share of 23.6% in 2024 [22] - Financial data shows revenues of 184 million, 249 million, and 339 million CNY from 2022 to 2024, with a compound annual growth rate of 35.7% [23] Group 7: Tuopu CNC - Tuopu CNC submitted its prospectus on May 26, 2025, aiming for a main board listing [27] - The company is the top supplier of five-axis CNC machine tools in China's aerospace market, with an 11.6% market share as of 2024 [29] - Financial data indicates revenues of 136 million, 335 million, and 531 million CNY from 2022 to 2024, with a compound annual growth rate of 97.9% [29] Group 8: Xiantong Pharmaceutical - Xiantong Pharmaceutical submitted its prospectus on May 26, 2025, planning to list on the Hong Kong Stock Exchange [32] - The company is the first in China to obtain approval for innovative radioactive drugs, focusing on oncology and neurodegenerative diseases [32] Group 9: Ledong Robotics - Ledong Robotics submitted its prospectus on May 30, 2025, aiming for a main board listing [35] - The company has a customer retention rate of approximately 90% in 2024, with a compound annual growth rate of about 41.4% in revenues from 2022 to 2024 [36] Group 10: Saintong Special Medical - Saintong Special Medical submitted its prospectus on May 30, 2025, planning to list on the Hong Kong Stock Exchange [38] - The company ranks first among domestic special medical food brands in China, with a market share of 6.3% as of 2024 [39] - Financial data shows revenues of 491 million, 654 million, and 834 million CNY from 2022 to 2024, with a compound annual growth rate of 30.3% [39] Group 11: Jushuitan - Jushuitan updated its prospectus on May 22, 2025, continuing its listing process on the Hong Kong Stock Exchange [41] - The company is the largest e-commerce SaaS ERP provider in China, holding a 24.4% market share as of 2024 [42] - Financial data indicates revenues of 523 million, 697 million, and 910 million CNY from 2022 to 2024, with a compound annual growth rate of 31.9% [42]

Core Viewpoint - Shanghai Topu Numerical Control Technology Co., Ltd. has submitted its IPO application to the Hong Kong Stock Exchange after two unsuccessful attempts at the Sci-Tech Innovation Board, marking a significant step in its growth trajectory [1][8]. Group 1: Company Overview - Founded in May 2007 by Wang Yuhan, Li Yuhao, and two other shareholders, the company specializes in the research, design, production, and sales of high-end intelligent manufacturing equipment [4]. - The company achieved profitability in 2024, with a revenue compound annual growth rate (CAGR) of 97.9% over the past two years [2][5]. Group 2: Market Position and Product Offering - In 2024, Topu ranked first in the Chinese aerospace five-axis CNC machine tool market with a market share of 11.6%, and fifth among all suppliers in the five-axis CNC machine tool market with a 4.3% share [4]. - The five-axis CNC machine tool market is projected to grow from 10.8 billion yuan in 2024 to 27 billion yuan by 2029, at a CAGR of 20.1% [4]. - The product portfolio includes aerospace intelligent manufacturing equipment, compact general-purpose five-axis machine tools, and large-size carbon fiber composite five-axis machine tools [4]. Group 3: Financial Performance - Revenue for the years 2022 to 2024 was 136 million yuan, 335 million yuan, and 532 million yuan, respectively, with net profits of -197 million yuan, -62 million yuan, and 6.886 million yuan, indicating a turnaround to profitability in 2024 [5][6]. - In 2024, 94.7% of total revenue was derived from the sales of aerospace intelligent manufacturing equipment [6]. Group 4: IPO Journey and Future Plans - This marks the third attempt for the company to go public, having previously submitted applications in June 2019 and June 2020, both of which were withdrawn or terminated [8]. - The funds raised from the IPO will be allocated for research and development, expanding sales and marketing networks, potential acquisitions, and repaying part of the interest-bearing bank loans [9].

Core Viewpoint - Shanghai Topu Numerical Control Technology Co., Ltd. (referred to as "Topu Numerical Control") has submitted its prospectus for an IPO on the Hong Kong Stock Exchange, aiming to raise funds for R&D, sales network development, potential acquisitions, and debt repayment [1][6]. Financial Information - As of the end of 2024, Topu Numerical Control's revenue for 2022, 2023, and 2024 was approximately RMB 136 million, RMB 335 million, and RMB 532 million, respectively, with net profits of approximately -RMB 197 million, -RMB 62.34 million, and RMB 6.886 million [7]. - The adjusted net profits for the same years were -RMB 198 million, -RMB 61.049 million, and RMB 133.75 million [7]. Debt and Financing - The company has bank operating loans of approximately RMB 90 million, with interest rates ranging from 2.55% to 3.4%, maturing between April 21, 2026, and February 18, 2028 [3]. - As of the end of 2024, approximately RMB 32.08 million of the company's loans were secured by land use rights valued at approximately RMB 8.121 million, guaranteed by Wang Yuhan, the co-founder and controlling shareholder [4]. Shareholding Structure - Wang Yuhan directly holds 36.82% of Topu Numerical Control, while the employee stock ownership platform controlled by him holds an additional 1.93%, giving him a total control of 38.74% of the company [4][5]. - Co-founder and executive director Li Yuhao holds 9.4% of the shares [4]. Business Focus - Topu Numerical Control specializes in high-end intelligent manufacturing equipment, primarily focusing on the research, design, production, and sales of five-axis CNC machine tools, catering to the advanced manufacturing needs of the aerospace sector in China [6][8].

Group 1 - On May 27, Paige Biopharma-B listed on the Hong Kong Stock Exchange at a price of HKD 11.56, experiencing a significant drop of 25.90% by the end of the trading day, indicating market concerns over its valuation and growth prospects despite its focus on innovative therapies for chronic diseases [1] - Muyuan Foods submitted a listing application to the Hong Kong Stock Exchange on May 27, positioning itself as a global leader in the pig farming industry with a complete industry chain covering breeding, farming, feed production, slaughtering, and meat processing, and has been the world's largest pig producer for four consecutive years [2] - Zijin Mining announced plans to spin off its subsidiary, Zijin Gold International, for a listing on the Hong Kong Stock Exchange, which involves restructuring and integrating several overseas gold mining assets, enhancing its market competitiveness and global resource layout [3] - Shanghai Topway CNC Technology Co., Ltd. submitted an IPO prospectus to the Hong Kong Stock Exchange on May 26, focusing on high-end intelligent manufacturing equipment, particularly five-axis CNC machine tools, with projected revenues of CNY 136 million, CNY 335 million, and CNY 532 million for 2022, 2023, and 2024 respectively [4] Group 2 - The Hang Seng Index closed at 23,381.99 with a gain of 0.43% on May 27, while the Hang Seng Tech Index and the National Enterprises Index also saw increases of 0.48% and 0.38% respectively [5]

Group 1: Acquisition and Business Adjustments - The company is in the process of acquiring Southern Power Grid Comprehensive Energy (Foshan) Co., Ltd., but has not yet signed a formal equity transfer agreement, indicating uncertainty in the implementation process [2] - The company has adjusted its main business focus and currently does not engage in artificial intelligence-related activities, concentrating instead on high-end intelligent manufacturing equipment, particularly in the new energy battery automation sector [3] Group 2: Financial Performance - In 2024, the company reported a 10.86% decrease in operating revenue, while net profit increased by 18.63%, attributed to cost control measures and the divestment of loss-making assets [3] - The company plans not to distribute cash dividends or issue bonus shares for the fiscal year ending December 31, 2024, due to negative distributable profits [3] Group 3: Inventory and Construction Projects - The company's inventory decreased by 22.94% in 2024, while construction in progress increased by 60.43%, with ongoing projects expected to be disclosed as they progress [4] Group 4: Market Expansion and R&D - The company is cautiously optimistic about expanding into overseas markets, having successfully acquired new clients in Japan and Thailand in 2024, with plans to deepen relationships with overseas battery manufacturers in 2025 [4] - The company aims to enhance its R&D efforts in lithium battery equipment, focusing on product adaptability and collaboration with downstream clients for new technology development [3]